Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

CUSIP: 92511W207

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 3 signals
Share change
0
SEC-reported price per share
$4.80
Number of holders
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
8,810,762

Security key

92511W207

Report period

Q3 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Paul B. Manning
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
5/15
Latest evidence
14 Aug 2026
3/4/5 13D/G 13F Lead comparable stake: 50% 10 rows are not safely comparable across share classes. 13D/G row: Paul B. Manning Showing 1-6 of 15 holder rows.

Quick read

Paul B. Manning leads the comparable SEC ownership view at 50%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paul B. Manning's linked filing trail.
Comparable ownership Top 5
Paul B. Manning 50%
Caligan Partners LP 10%
Affinity Asset Advisors, LLC 5.5%
ARMISTICE CAPITAL, LLC 5%
PERCEPTIVE ADVISORS LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Paul B. Manning
3/4/5 13D/G
Director, 10%+ Owner
50%
Reported 13D/G · 25 Nov 2025
$32,171,572
31,591,877 shares
mixed-class rows
+$17,505,157 25 Nov 2025
Caligan Partners LP
13D/G 3/4/5 13F
Other* · Company
10%
Reported 13D/G · 26 Dec 2025
$43,635,492
6,503,054 shares
$0 26 Dec 2025
Affinity Asset Advisors, LLC
13D/G 13F
Company
5.5%
Reported 13D/G · 22 Jan 2026
$7,346,762
884,172 shares
$0 22 Jan 2026
ARMISTICE CAPITAL, LLC
13D/G 13F
Company
5%
Reported 13D/G · 31 Dec 2025
$3,649,153
439,657 shares
-$1,656,149 31 Dec 2025
PERCEPTIVE ADVISORS LLC
3/4/5 13D/G
10%+ Owner
1.6%
Reported 13D/G · 31 Mar 2025
$51,398,078
7,099,182 shares
— 27 Dec 2023
BKB Growth Investments, LLC
3/4/5
10%+ Owner
—
denominator unverified
$27,822,292
3,348,372 shares
— 25 Nov 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
152
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
43
Q3 2026 holders
2
Holder diff
-41
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .